Rare cutaneous malignancies of childhood

Current Opinion in Pediatrics

Volumn 11, Issue 5, 1999, Pages 464-470

  Hoang, Minh Tuan Richard ^a   Friedlander, Sheila Fallon ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CHILDHOOD CANCER; CONGENITAL NEVUS; DYSPLASTIC NEVUS; FEMALE; HUMAN; MALE; MELANOMA; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PROGNOSIS; PUVA; REVIEW; RISK FACTOR; SKIN EXAMINATION; SUN EXPOSURE;

ADOLESCENT; CHILD; DYSPLASTIC NEVUS SYNDROME; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MELANOMA; MYCOSIS FUNGOIDES; NEVUS; PROGNOSIS; RISK FACTORS; SKIN NEOPLASMS; SUNBURN;

EID: 0032828605     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199910000-00016     Document Type: Review

References (57)

1. Knight PJ, Reiner CB: Superficial lumps in children: what, when, and why? Pediatrics 1983, 72:147-153.
2. Rigel DS, Friedman RJ, Kopf AW: The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996, 34:839-847.
3. Berwick M: Worldwide incidence and mortality-rising or falling? Skin Cancer Found J 1998, 40-41, 96.
4. Chamlin SL, Williams ML: Moles and melanoma. Curr Opin Ped 1998, 10:398-404. The authors of this well-referenced and comprehensive article detail the risk factors for childhood melanoma. They briefly mention melanoma prevention and therapy.
5. Ruiz-Maldonado R, de la Luz Orozco-Covarrubias M: Malignant melanoma in children. Arch Dermatol 1997, 133:363-371.
6. Berg P, Lindelof B: Differences in malignant melanoma between children and adolescents. Arch Dermatol 1997, 133:295-297.
7. Brodkin RJ, Altman EM: Controlling malignant melanoma: a focus on pediatricians. AJDC 1993, 147:875-881.
8. Osterlind A, Tucker MA, Stone BJ, Jensen OM: The Danish case-control study of cutaneous malignant melanoma: II: importance of UV-light exposure. Int J Cancer 1988, 42:319-324.
9. Weinstock MA, Colditz GA, Willett WC, Stampfer MJ, Bronstein BR, Mihm MC, Speizer FE: Nonfamilial cutaneous melanoma incidence in women associated with sun exposure before 20 years of age. Pediatrics 1989, 84:199-204.
10. Autier P, Dore JF: Influence of sun exposures during childhood and during adulthood on melanoma risk. Int J Cancer 1998, 77:533-537.
11. Katsambas A, Nicolaidou E: Cutaneous malignant melanoma and sun exposure. Arch Dermatol 1996, 132:444-450.
12. Elwood JM, Jopson J: Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997, 73:198-203.
13. Gilchrest B, Eller MS, Geller AC, Yaar M: The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999, 340:1341-1347. This excellent review of the data thus far supports the relationship between ultraviolet exposure and the development of malignant melanoma.
14. Autier P, Dore JF, Schifflers E, Cesarini JP, Bollaerts A, Koelmel KF, et al.: Melanoma and use of sunscreens: an EORTC (European Organization for Research and Treatment of Cancer) case-control study in Germany, Belgium, and France. Int J Cancer 1995, 61:749-755.
15. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N: Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 1995, 5:59-65.
16. Autier P, Dore JF, Renard F, Luther H, Cattaruzza MS, Gefeller O, Grivegnee A: Melanoma and sunscreen use: need for studies representative of actual behaviors. Melanoma Res 1997, 7(suppl2): 115-120.
17. Moan J: Solar radiation and melanomas: is there any doubt about the connection? Tidsskr Nor Laegeforen 1998, 118:2321-2325.
18. Ley RD: Ultraviolet radiation A-induced precursors of cutaneous melanoma in Monodelphis domestica. Cancer Res 1997, 57:3682-3684.
19. Wulf HC, Stender IM, Lock-Andersen J: sunscreens used at the beach do not protect against erythema: a new definition of SPF is proposed. Photoderatol Photoimmunol Photomed 1997, 13:129-132.
20. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ: Cutaneous melanoma in women; I: exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiology 1995, 141:923-933.
21. Naylor MF: Sunscreens: a dermatologist's perspective. Skin Cancer Found J 1998, 83:21-22.
22. Swerdlow AJ, English J, Mackie RM, O'Doharty CJ, Hunter JAA, Clark J, Hole DJ: Benign melanocytic nevi as a risk factor for malignant melanoma. BMJ 1986, 292:1555-1559.
23. Holly EA, Kelly JW, Shpall SN, Chiu SH: Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987, 17:459-468.
24. Whiteman DC, Valery P, McWhirter W, Green AC: Risk factors for childhood melanoma in Queensland, Australia. Int J Cancer 1997, 70:26-31.
25. Gallagher RP, McLean DI, Yang PC, Coldman AJ, Silver HKB, Spinelli JJ, Beagrie M: Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children: similarities to melanoma: the Vancouver mole study. Arch Dermatol 1990, 126:770-776.
26. Pope DJ, Sorahan T, Marsden JR, Ball PM, Grimley RP, Peck IM: Benign pigmented nevi in children: prevalence and associated factors; the West Midlands, United Kingdom mole study. Arch Dermatol 1992, 128:1201-1206.
27. Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE, Tate BJ: Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994, 30:40-48.
28. Duvic M, Lowe L, Rapini R, Rodriguez S, Levy ML: Eruptive dysplastic nevi associated with human immunodeficiency virus infection. Arch Dermatol 1989, 125:397-401.
29. Hughes BR, Cunliffe WJ, Bailey CC: Excess benign melanocytic nevi after chemotherapy for malignancy in childhood. BMJ 1989, 299:88-91.
30. Smith CH, McGregor JM, Barker JNWN, Morris RW, Rigden SPA, MacDonald DM: Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol 1993, 28:51-55.
31. Greene MH, Young TI, Clark WH: Malignant melanoma in renal transplant patients. Lancet 1981, 1:1196-1199.
32. Kopf AW, Bart RS, Hennessey P: Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1979, 1:123-130.
33. Swerdlow AJ, English JSC, Qiao Z: The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol 1995, 32:595-599.
34. DeDavid M, Orlow SJ, Provost N, Marghoob AA, Rao BK, Huang CL, et al.: A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature. J Am Acad Dermatol 1997, 36:409-416.
35. Egan CL, Oliveria SA, Elenitsas R, Hanson J, Halpern AC: Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients. J Am Acad Dermatol 1998, 39:923-932.
36. Sahin S, Levin L, Kopf AW, Rao BK, Triola M, Koenig K, et al.: Risk of melanoma in medium-sized congenital melanocytic nevi: a follow-up study. J Am Acad Dermatol 1998, 39:428-433.
37. Liu L, Dilworth D, Gao L, Monzon J, Summers A, Lassam N, Hogg D: Mutation of the CDKN2A 5 UTR creates an aberrant initiation codon and predisposes to melanoma. Nature Genet 1999, 21:128-132.
38. Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, Guerry D 4th, et al.: Acquired precursors of cutaneous malignant melanoma: the familial dysplastic nevus syndrome. N Engl J Med 1985, 312:91-97.
39. Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, et al.: Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA 1907, 277:1439-1444.
40. Scalzo DA, Hida CA, Toth G, Sober AJ, Mihm MC: Childhood melanoma: a clinicopathological study of 22 cases. Melanoma Res 1997, 7:83-88.
41. Brady MS, Coit DG: Sentinel lymph node evaluation in melanoma. Arch Dermatol 1997, 133:1014-1020.
42. Demierre M-F, Koh HK: Adjuvant therapy for cutaneous malignant melanoma. J Am Acad Dermatol 1997, 36:747-764.
43. Brady MS, Weinberg H, Kraus D, Lewis JJ, Coit DG, Quaiglia MP et al.: Lymphatic mapping in the management of malignant melanoma in children Pediatr Derm 1998; 15:421-425.
44. Koch SE, Zackheim HS, Williams ML, Fletcher V, Leboit PE: Mycosis fungoides beginning in childhood and adolescence. J Am Acad Dermatol 1987, 17:563-570.
45. Peters MS, Thibodeau SN, White JW, Winkelmann RK: Mycosis fungoides in children and adolescents. J Am Acad Dermatol 1990, 22:1011-1018.
46. EI-Hoshy K, Hashimoto K: Adolescence mycosis fungoides: an unusual presentation with hypopigmentation. J Dermatol 1995, 22:424-427.
47. Hickham PR, McBurney EI, Fitzgerald RL: CTCL in patients under 20 years of age: a series of five cases. Pediatr Dermatol 1997, 14:93-97.
48. 48 Tay Y-K, Weston WL, Aeling JL: Treatment of childhood cutaneous T-cell lymphoma with alpha-interferon plus PUVA, Pediatr Dermatol 1996, 13:496-500.
49. Howard R, Tsuchiya A: Adult skin disease in the pediatric patient. Dermatol Clin 1998, 16:593-608.
50. Camacho FM, Burg G, Moreno JC, Campora RC, Villar JL: Granulomatous slack skin in childhood. Pediatr Dermatol 1997, 14:204-208.
51. Meister L, Duarte AM, Davis J, Perez JL, Schachner LA: Sezary syndrome in an 11-year-old girl. J Am Acad Dermatol 1993, 28:93-95.
52. Pancake BA, Zucker-Franklin D, Contavas EE: The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. J Clin Invest 1995, 95:547-554.
53. Zucker-Franklin D, Kosann MK, Pancake BA, Ramsay DL, Soter NA: Hypopigmented mycosis fungoides associated with human T cell lymphotropic virus type 1 tax in a pediatric patient. Pediatrics 1999, 103:1039-1044.
54. Bergman R, Faclieru D, Sahar D, Sander CA, Kerner H, Ben-Aryeh Y, et al.: Immunophenotyping and T-cell receptor y gene rearrangement analysis as an adjunct to the histopathologic diagnosis of mycosis fungoides. J Am Acad Dermatol 1998, 39:554-559.
55. Kim YH, Chow S, Varghese A, Hoppe RT: Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol 1999, 135:26-32. Long-term outcome is excellent in patients with early-stage mycosis fungoides.
56. Zackheim HS, Kashani-Sabet M, Amin S: Topical corticosteroids for mycosis fungoides: experience in 79 patients. Arch Dermatol 1998, 134:949-954.
57. Zackheim HS, Amin S, Kashani-Sabet M, McMillan A: Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol 1999, 40:418-425.